R&D Why pharma’s future may run through your local blood centre With demand for cell and gene therapies (CGTs) growing rapidly, blood centres are indispensable collaborators.
Events Partner Content 3rd Annual Computational Drug Development (CDD) for Biologic... CDD for Biologics | 13-15 November 2018 | Boston, USA
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
